Trial Outcomes & Findings for Randomized Controlled Trial of a Patient Activation Tool in Pediatric Appendicitis (Antibiotics Alone vs. Appendectomy) (NCT NCT02110485)
NCT ID: NCT02110485
Last Updated: 2019-11-19
Results Overview
Decision Self-Efficacy will be measured using the Decision Self-Efficacy Scale which measures the participant's confidence in their ability to make decisions and consists of 11 questions regarding different aspects of decision making. This will be measured 1 hour after treatment decision has been made. The scale is a 5 point scale ranging from 0-not at all confident to 4-very confident. Higher scores are better. Scoring includes summing all items, dividing by 11; and multiplying by 25. A score of 0 means "extremely low self efficacy and a score of 100 means extremely high self efficacy
COMPLETED
NA
200 participants
1 hour following decision
2019-11-19
Participant Flow
Participant milestones
| Measure |
Patient Activation Tool
Patients and their caregivers will receive the patient activation tool in addition to standard consultation
Patient Activation Tool: An interactive tablet based tool designed to (1) teach patient activation strategies; (2) provide evidence-based information about a health condition, (3) help patient/caregiver dyads recognize and clarify their own values, and (4) provide guidance in decision making and communication among those involved with the decision.
|
Standard Consultation
Patients and their caregivers will receive standard consultation alone
|
|---|---|---|
|
Overall Study
STARTED
|
98
|
102
|
|
Overall Study
COMPLETED
|
91
|
83
|
|
Overall Study
NOT COMPLETED
|
7
|
19
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Randomized Controlled Trial of a Patient Activation Tool in Pediatric Appendicitis (Antibiotics Alone vs. Appendectomy)
Baseline characteristics by cohort
| Measure |
Patient Activation Tool
n=98 Participants
Patients and their caregivers will receive the patient activation tool in addition to standard consultation
Patient Activation Tool: An interactive tablet based tool designed to (1) teach patient activation strategies; (2) provide evidence-based information about a health condition, (3) help patient/caregiver dyads recognize and clarify their own values, and (4) provide guidance in decision making and communication among those involved with the decision.
|
Standard Consultation
n=102 Participants
Patients and their caregivers will receive standard consultation alone
|
Total
n=200 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
98 Participants
n=5 Participants
|
102 Participants
n=7 Participants
|
200 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
12 years
n=5 Participants
|
13 years
n=7 Participants
|
12 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
39 Participants
n=5 Participants
|
41 Participants
n=7 Participants
|
80 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
59 Participants
n=5 Participants
|
61 Participants
n=7 Participants
|
120 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
6 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
88 Participants
n=5 Participants
|
85 Participants
n=7 Participants
|
173 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
3 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
98 Participants
n=5 Participants
|
102 Participants
n=7 Participants
|
200 Participants
n=5 Participants
|
|
Insurance Status
Private Insurance
|
59 Participants
n=5 Participants
|
67 Participants
n=7 Participants
|
126 Participants
n=5 Participants
|
|
Insurance Status
Medicaid
|
37 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
65 Participants
n=5 Participants
|
|
Insurance Status
No insurance
|
2 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 hour following decisionDecision Self-Efficacy will be measured using the Decision Self-Efficacy Scale which measures the participant's confidence in their ability to make decisions and consists of 11 questions regarding different aspects of decision making. This will be measured 1 hour after treatment decision has been made. The scale is a 5 point scale ranging from 0-not at all confident to 4-very confident. Higher scores are better. Scoring includes summing all items, dividing by 11; and multiplying by 25. A score of 0 means "extremely low self efficacy and a score of 100 means extremely high self efficacy
Outcome measures
| Measure |
Patient Activation Tool
n=98 Participants
Patients and their caregivers will receive the patient activation tool in addition to standard consultation
Patient Activation Tool: An interactive tablet based tool designed to (1) teach patient activation strategies; (2) provide evidence-based information about a health condition, (3) help patient/caregiver dyads recognize and clarify their own values, and (4) provide guidance in decision making and communication among those involved with the decision.
|
Standard Consultation
n=102 Participants
Patients and their caregivers will receive standard consultation alone
|
|---|---|---|
|
Decision Self-Efficacy Scale
|
100 units on a scale
Interval 95.5 to 100.0
|
100 units on a scale
Interval 97.7 to 100.0
|
PRIMARY outcome
Timeframe: 1 day from enrollmentHealthcare satisfaction will be measured at the time of discharge (average 1-2 days) using the PedsQL 3.0 Healthcare Satisfaction Generic Module- Parent Report. This survey measures the parent's satisfaction with the care their child received and measures six dimensions (information, inclusion of family, communication, technical skills, emotional needs, and overall satisfaction) using 24 items. Parents chose a score from 0-4; 0=never happy; 1=sometimes happy; 2=often happy; 3=almost always happy; 4=always happy, followed by the ability to respond "not applicable" Subscale scores are not reported If not applicable is chosen, the item is not scored nor included n the final sum. Scoring is based on a total sum for all items as well as a subscale sum for each of the 6 dimensions. Higher scores are better. Total scores range from 0-96
Outcome measures
| Measure |
Patient Activation Tool
n=98 Participants
Patients and their caregivers will receive the patient activation tool in addition to standard consultation
Patient Activation Tool: An interactive tablet based tool designed to (1) teach patient activation strategies; (2) provide evidence-based information about a health condition, (3) help patient/caregiver dyads recognize and clarify their own values, and (4) provide guidance in decision making and communication among those involved with the decision.
|
Standard Consultation
n=102 Participants
Patients and their caregivers will receive standard consultation alone
|
|---|---|---|
|
PedsQL 3.0 Healthcare Satisfaction Generic Module (Parent Report)
|
98.3 units on a scale
Interval 91.7 to 100.0
|
99.0 units on a scale
Interval 94.7 to 100.0
|
PRIMARY outcome
Timeframe: 1 year folow-upDisability days will be assessed at 1 year follow-up. Disability days is a composite of inpatient hospital days, emergency department visits, primary care physician visits and all days with limited activities referable to their appendicitis.
Outcome measures
| Measure |
Patient Activation Tool
n=83 Participants
Patients and their caregivers will receive the patient activation tool in addition to standard consultation
Patient Activation Tool: An interactive tablet based tool designed to (1) teach patient activation strategies; (2) provide evidence-based information about a health condition, (3) help patient/caregiver dyads recognize and clarify their own values, and (4) provide guidance in decision making and communication among those involved with the decision.
|
Standard Consultation
n=91 Participants
Patients and their caregivers will receive standard consultation alone
|
|---|---|---|
|
Disability Days
|
5 Days
Interval 2.0 to 15.0
|
6 Days
Interval 2.0 to 11.0
|
SECONDARY outcome
Timeframe: 1 hourParent activation will be assessed with the Patient Activation Measure® (Parent-PAM®) using a version of healthy child parent PAM® adapted with permission. This 13 item scale and was derived from the short form version of the Patient Activation Measure®. The Parent-PAM® is used to assess the parent's activation in the management of their child's health. The 13 items have response options ranging from 1=strongly disagree to 4 strongly agree with an option to respond as "not applicable". A total PAM score is calculated by summing all items and dividing by the number of items answered and multiplied by 13; total scores can range from 13-52. This score is transformed to a scale ranging from 0-100 with higher PAM scores indicating higher patient activation.
Outcome measures
| Measure |
Patient Activation Tool
n=98 Participants
Patients and their caregivers will receive the patient activation tool in addition to standard consultation
Patient Activation Tool: An interactive tablet based tool designed to (1) teach patient activation strategies; (2) provide evidence-based information about a health condition, (3) help patient/caregiver dyads recognize and clarify their own values, and (4) provide guidance in decision making and communication among those involved with the decision.
|
Standard Consultation
n=102 Participants
Patients and their caregivers will receive standard consultation alone
|
|---|---|---|
|
Patient Activation Measure (PAM)
|
91 units on a scale
Interval 75.0 to 100.0
|
100 units on a scale
Interval 77.7 to 100.0
|
SECONDARY outcome
Timeframe: 1 yearReadmissions rates to any hospital within 1 year wil be assessed
Outcome measures
| Measure |
Patient Activation Tool
n=83 Participants
Patients and their caregivers will receive the patient activation tool in addition to standard consultation
Patient Activation Tool: An interactive tablet based tool designed to (1) teach patient activation strategies; (2) provide evidence-based information about a health condition, (3) help patient/caregiver dyads recognize and clarify their own values, and (4) provide guidance in decision making and communication among those involved with the decision.
|
Standard Consultation
n=91 Participants
Patients and their caregivers will receive standard consultation alone
|
|---|---|---|
|
Number of Participants Readmitted
|
15 Participants
|
15 Participants
|
SECONDARY outcome
Timeframe: 30 day follow-upThe PedsQL Pediatric Quality of Life Inventory is a 23 item survey with response options offered on a 5 point scale; 0= never been a problem; 1=almost never a problem; 2=sometimes a problem; 3=often a problem; 4=almost always a problem. A total score is summed for each of the 4 dimensions as well as an overall score for the entire measure. The PedsQL Family Impact Module Scales include subscales: physical functioning; emotional functioning; social functioning; cognitive functioning; communication; worry; family functioning; daily activities; and family relationships. The options for this 5-point scale range from 0= never a problem to 4=always a problem). Items are reverse-scored and high scores indicate better family functioning. A total summed score is utilized. Each subscale can be summed individually and divided by the number of items in that. Total scores for this measure range from 0-92
Outcome measures
| Measure |
Patient Activation Tool
n=71 Participants
Patients and their caregivers will receive the patient activation tool in addition to standard consultation
Patient Activation Tool: An interactive tablet based tool designed to (1) teach patient activation strategies; (2) provide evidence-based information about a health condition, (3) help patient/caregiver dyads recognize and clarify their own values, and (4) provide guidance in decision making and communication among those involved with the decision.
|
Standard Consultation
n=76 Participants
Patients and their caregivers will receive standard consultation alone
|
|---|---|---|
|
PedsQL Pediatric Quality of Life Inventory and PedsQL Family Impact Module Scales
|
88.0 units on a scale
Interval 79.3 to 96.7
|
88.0 units on a scale
Interval 81.0 to 96.7
|
Adverse Events
Patient Activation Tool
Standard Consultation
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place